Astera Labs (NASDAQ:ALAB) Stock Price Down 9.4% – What’s Next?

by · The Markets Daily

Shares of Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) were down 9.4% during mid-day trading on Friday . The stock traded as low as $158.50 and last traded at $157.4040. Approximately 1,130,458 shares traded hands during trading, a decline of 79% from the average daily volume of 5,356,042 shares. The stock had previously closed at $173.70.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. TD Cowen reduced their target price on Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a research note on Wednesday, November 5th. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Barclays reissued an “equal weight” rating and set a $155.00 price objective on shares of Astera Labs in a report on Monday, October 20th. Bank of America assumed coverage on shares of Astera Labs in a research note on Friday, October 3rd. They issued a “neutral” rating and a $230.00 target price on the stock. Finally, Raymond James Financial started coverage on Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating for the company. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $188.17.

Read Our Latest Report on ALAB

Astera Labs Price Performance

The stock’s fifty day simple moving average is $166.62 and its two-hundred day simple moving average is $153.61. The company has a market capitalization of $25.14 billion, a price-to-earnings ratio of 134.10, a PEG ratio of 2.77 and a beta of 1.51.

Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same quarter in the prior year, the firm earned $0.23 EPS. The company’s revenue for the quarter was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the sale, the director directly owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This trade represents a 8.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Michael Truett Tate sold 11,430 shares of the business’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the transaction, the chief financial officer directly owned 192,297 shares of the company’s stock, valued at approximately $27,823,452.93. This trade represents a 5.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 586,936 shares of company stock worth $89,331,140. 12.50% of the stock is currently owned by insiders.

Institutional Trading of Astera Labs

Several hedge funds have recently bought and sold shares of ALAB. Value Aligned Research Advisors LLC grew its position in Astera Labs by 16.7% in the 3rd quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock worth $269,881,000 after purchasing an additional 197,320 shares during the last quarter. Allworth Financial LP grew its holdings in Astera Labs by 16.3% in the 3rd quarter. Allworth Financial LP now owns 3,038 shares of the company’s stock worth $595,000 after buying an additional 426 shares in the last quarter. IFP Advisors Inc increased its position in Astera Labs by 11.2% in the 3rd quarter. IFP Advisors Inc now owns 4,599 shares of the company’s stock valued at $900,000 after acquiring an additional 464 shares during the period. Swiss Life Asset Management Ltd increased its position in Astera Labs by 78.8% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 6,052 shares of the company’s stock valued at $1,185,000 after acquiring an additional 2,668 shares during the period. Finally, Polar Asset Management Partners Inc. bought a new stake in Astera Labs during the 3rd quarter valued at $349,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Further Reading